1. Home
  2. MTX vs VCEL Comparison

MTX vs VCEL Comparison

Compare MTX & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTX
  • VCEL
  • Stock Information
  • Founded
  • MTX 1968
  • VCEL 1989
  • Country
  • MTX United States
  • VCEL United States
  • Employees
  • MTX N/A
  • VCEL N/A
  • Industry
  • MTX Major Chemicals
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MTX Industrials
  • VCEL Health Care
  • Exchange
  • MTX Nasdaq
  • VCEL Nasdaq
  • Market Cap
  • MTX 1.9B
  • VCEL 2.1B
  • IPO Year
  • MTX 1992
  • VCEL 1997
  • Fundamental
  • Price
  • MTX $55.88
  • VCEL $40.46
  • Analyst Decision
  • MTX Strong Buy
  • VCEL Strong Buy
  • Analyst Count
  • MTX 2
  • VCEL 8
  • Target Price
  • MTX $80.00
  • VCEL $62.00
  • AVG Volume (30 Days)
  • MTX 289.0K
  • VCEL 565.6K
  • Earning Date
  • MTX 07-24-2025
  • VCEL 05-08-2025
  • Dividend Yield
  • MTX 0.79%
  • VCEL N/A
  • EPS Growth
  • MTX N/A
  • VCEL 521.85
  • EPS
  • MTX N/A
  • VCEL 0.05
  • Revenue
  • MTX $2,075,800,000.00
  • VCEL $238,541,000.00
  • Revenue This Year
  • MTX $0.83
  • VCEL $23.03
  • Revenue Next Year
  • MTX $4.68
  • VCEL $24.52
  • P/E Ratio
  • MTX N/A
  • VCEL $667.75
  • Revenue Growth
  • MTX N/A
  • VCEL 14.80
  • 52 Week Low
  • MTX $49.54
  • VCEL $37.39
  • 52 Week High
  • MTX $90.30
  • VCEL $63.00
  • Technical
  • Relative Strength Index (RSI)
  • MTX 43.89
  • VCEL 44.71
  • Support Level
  • MTX $57.62
  • VCEL $40.38
  • Resistance Level
  • MTX $60.51
  • VCEL $42.57
  • Average True Range (ATR)
  • MTX 1.36
  • VCEL 1.69
  • MACD
  • MTX -0.04
  • VCEL -0.02
  • Stochastic Oscillator
  • MTX 13.78
  • VCEL 24.76

About MTX Minerals Technologies Inc.

Minerals Technologies Inc mines, produces, and sells mineral-based products. The firm organizes itself into two segments: The Consumer & Specialties segment that derives maximum revenue, serves consumer end markets directly with mineral-to-market finished products and also provides specialty mineral-based solutions and technologies that are an essential component of our customers' finished products. The Engineered Solutions segment serves industrial end markets with engineered systems, mineral blends, and technologies that are designed to improve our customers' manufacturing processes and projects. The majority of revenue comes from the United States.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: